• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Insufficient Information (4580)
Event Date 04/27/2022
Event Type  Injury  
Manufacturer Narrative
The meter and test strips were requested for investigation and have not been received at this time.If the product is returned in the future, a follow-up report will be submitted. on a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and the results have passed the internal inspection. occupation is patient/consumer.
 
Event Description
We received an allegation that a patient who uses the coaguchek xs meter with serial number (b)(4) fell and hit her head while in the shower or bathroom.On (b)(6) 2022, the patient initially called to ask for assistance performing a test.During the call, the patient stated that on (b)(6) 2022, she fell in the shower or bathroom and hit her head.She reportedly does not remember anything, only that she fell.Upon review of the meter results, the meter result on (b)(6) 2022 at 10:49 am was 2.7 inr.It is unclear if the patient fell because of a brain bleed or if the brain bleed was caused by the trauma.She was reportedly brought to the hospital where a computerized tomography (cat scan) reportedly showed blood clots in her upper right and left atrium.She was reportedly taken off her warfarin in the hospital and was treated with another medication.Reportedly the patient did not know any results of her bloodwork and did not know whether her inr was checked while in the hospital.She reportedly stayed in the hospital for 10 days and then in a rehabilitation facility for 3 weeks.On (b)(6) 2022, she was reportedly started on warfarin.The therapeutic range was reported to be 2.0-3.0 inr.The patient's interval of testing was reported to be every 4-5 days since restarting warfarin.This mdr is being submitted in an abundance of caution.
 
Manufacturer Narrative
Mdr code - component code - new component code was updated.
 
Manufacturer Narrative
The customer's meter was returned for investigation.It was observed that the returned meter failed to power on.An examination of the battery compartment revealed corroded battery contacts (handling error) due to leaking batteries.The power supply of the device is interrupted no further investigation can be conducted on the customer's returned meter due to the corrosion.The root cause for the meter failing to power on is the contamination of the contacts due to improper handling or maintenance.Product labeling states "if you store the meter for a period of time, remove the batteries.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key15252889
MDR Text Key298171925
Report Number1823260-2022-02494
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702127104
UDI-Public00365702127104
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 11/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/18/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date11/30/2022
Device Catalogue Number04625374160
Device Lot Number54145321
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received11/03/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CARVEDILOL.; FLUOXETINE 40MG.; GABAPENTIN 300MG.; IRON.; LATANOPROST EYE DROPS.; OMEPRAZOLE.; POTASSIUM 20MG.; ROPINIROLE 1MG.; SILVER CENTRUM.; SPIRONOLACTONE.; STOOL SOFTENERS.; WARFARIN.
Patient Outcome(s) Hospitalization;
Patient Age88 YR
Patient SexFemale
Patient Weight73 KG
-
-